Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
---|---|---|---|---|---|---|
Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
Advanced Enzyme Technologies L | 1,767.97 | 388.76 | 1,691.12 | 3.36 | 3,242 | 22.8 |
MOREPEN LABORATORIES LTD. | 4581.18 | 266.89 | 4527.81 | 0.49 | 2836 | 22.5 |
GUJARAT THEMIS BIOSYN LTD. | 397.61 | 129.72 | 395.20 | 1.19 | 2663 | 50.6 |
Advanced Enzyme Technologies Limited, with Security Code 540025, is a leading player in the Biotechnology industry, categorized under the Healthcare sector, offering Equity instruments.
Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Sales | 72.1 | 77.1 | 79.6 | 82.5 | 85.3 | 96.5 | 91.1 | 92.4 | 85.9 | 77.3 |
Expenses | 60.6 | 58.2 | 58.5 | 59.3 | 60.6 | 70.0 | 66.6 | 63.2 | 65.0 | 63.9 |
Operating Profit | 11.5 | 18.9 | 21.2 | 23.3 | 24.8 | 26.6 | 24.5 | 29.2 | 20.9 | 13.5 |
OPM % | 15.9% | 24.55% | 26.6% | 28.2% | 29.03% | 27.56% | 26.93% | 31.65% | 24.34% | 17.48% |
Other Income | 1.2 | 2.0 | 3.8 | 2.8 | 51.2 | 0.8 | 3.6 | -15.7 | 53.9 | 1.7 |
Interest | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
Depreciation | 2.4 | 2.5 | 2.6 | 2.8 | 2.5 | 2.6 | 2.7 | 3.1 | 2.6 | 2.8 |
Profit before tax | 10.3 | 18.4 | 22.3 | 23.3 | 73.5 | 24.8 | 25.4 | 29.3 | 72.2 | 12.3 |
Tax % | 24.3% | 26.1% | 25.4% | 24.8% | 8.2% | 25.8% | 24.6% | 69.8% | 7.1% | 25.9% |
Net Profit | 7.8 | 13.6 | 16.6 | 17.5 | 67.5 | 18.4 | 19.1 | 3.1 | 67.1 | 9.1 |
EPS in Rs | 0.7 | 1.22 | 1.49 | 1.56 | 6.04 | 1.64 | 1.71 | 0.28 | 5.99 | 0.81 |
Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Sales | 138.7 | 142.1 | 138.7 | 147.3 | 157.8 | 160.9 | 157.8 | 154.5 | 146.1 | 169.1 |
Expenses | 99.0 | 100.4 | 94.6 | 103.3 | 106.5 | 107.2 | 102.5 | 103.4 | 103.7 | 113.9 |
Operating Profit | 39.7 | 41.7 | 44.2 | 44.0 | 51.3 | 53.8 | 55.4 | 51.2 | 42.4 | 55.3 |
OPM % | 28.6% | 29.3% | 31.8% | 29.9% | 32.5% | 33.4% | 35.1% | 33.1% | 29% | 32.7% |
Other Income | 3.9 | 8.5 | 7.0 | 6.7 | 6.1 | 14.4 | -5.6 | 7.0 | 9.6 | 7.7 |
Interest | 0.6 | 0.6 | 0.6 | 0.6 | 0.8 | 0.7 | 0.8 | 0.9 | 0.9 | 0.9 |
Depreciation | 8.8 | 9.1 | 8.4 | 8.6 | 8.7 | 8.6 | 9.3 | 8.6 | 8.9 | 9.0 |
Profit before tax | 34.1 | 40.5 | 46.2 | 41.4 | 47.9 | 58.9 | 54.7 | 48.7 | 42.2 | 53.0 |
Tax % | 23.1% | 31% | 23.7% | 29% | 26.6% | 27.8% | 24.6% | 28.1% | 20.9% | 26.7% |
Net Profit | 26.3 | 27.9 | 32.1 | 29.4 | 35.2 | 42.5 | 29.9 | 35.0 | 33.4 | 38.9 |
EPS in Rs | 2 | 2 | 2 | 2 | 3 | 3 | 2 | 3 | 2 | 3 |
Compounded Sales Growth | |
---|---|
10 Years: | 10% |
5 Years: | 10% |
3 Years: | 9% |
TTM: | 0% |
Compounded Profit Growth | |
---|---|
10 Years: | 29% |
5 Years: | 28% |
3 Years: | 20% |
TTM: | -14% |
Stock Price CAGR | |
---|---|
10 Years: | 0% |
5 Years: | 13% |
3 Years: | 1% |
1 Year: | -29% |
Compounded Sales Growth | |
---|---|
10 Years: | 10% |
5 Years: | 8% |
3 Years: | 8% |
TTM: | 4% |
Compounded Profit Growth | |
---|---|
10 Years: | 22% |
5 Years: | 5% |
3 Years: | 0% |
TTM: | 2% |
Stock Price CAGR | |
---|---|
10 Years: | 0% |
5 Years: | 13% |
3 Years: | 1% |
1 Year: | -29% |
Recent Bets
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
---|